We are live on
!
Find out more
C4 Therapeutics
CCCC
CCCC
123 hedge funds and large institutions have $221M invested in C4 Therapeutics in 2026 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 41 increasing their positions, 31 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
209% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 11
189% more call options, than puts
Call options by funds: $1.02M | Put options by funds: $352K
45% more capital invested
Capital invested by funds: $153M → $221M (+$68.8M)
32% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 31
22% more funds holding
Funds holding: 101 → 123 (+22)
4.2% more ownership
Funds ownership: 82.39% → 86.59% (+4.2%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
123
Holders Change
+22
Holders Change %
+21.78%
% of All Funds
1.51%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
34
Increased
41
Reduced
31
Closed
11
Calls
$1.02M
Puts
$352K
Net Calls
+$666K
Net Calls Change
+$80K
Top Buyers
| 1 |
JP Morgan Chase
New York
|
+$7.58M |
| 2 |
SCM
Squadron Capital Management
Westmont,
Illinois
|
+$5.3M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$4.86M |
| 4 |
Two Sigma Investments
New York
|
+$3.59M |
| 5 |
Goldman Sachs
New York
|
+$3.06M |
Top Sellers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$21.8M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$3.26M |
| 3 |
O
OrbiMed
New York
|
-$1.29M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.15M |
| 5 |
Walleye Capital
New York
|
-$481K |
